Hymovis® Hyaluronate, Modified, Non-crosslinked 8 mg / mL Injection 3 mL

Name: Osteoarthritis Agent
Brand: Hymovis®

HYMOVIS, SYR 24MG/3ML (2/EA)

McKesson #

1056253

Manufacturer #

89122049663

Brand

Hymovis®

Manufacturer

Fidia Pharma USA Inc

Country of Origin

Unknown

Application

Osteoarthritis Agent

Container Type

Prefilled Syringe

Dosage Form

Injection

Generic Drug Code

38988

Generic Drug Name

Hyaluronate, Modified, Non-crosslinked

NDC Number

89122049663

Strength

8 mg / mL

Type

Intra-articular

UNSPSC Code

51202002

Volume

3 mL

HYMOVIS® is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy or simple analgesics (e.g., acetaminophen)
HYMOVIS® is a sterile, non-pyrogenic, viscoelastic hydrogel contained in a single-use syringe
HYMOVIS® has a hyaluronan (HYADD®4) concentration of 8 mg/mL, dissolved in physiologic saline
HYMOVIS® is supplied in a set of 2 single-use 5 mL syringes, each containing a 3 mL dose of treatment to be injected one week apart